Live Chat on The Biotech Forum sees frequent discussion of specific covered call trades. To see what covered call trades I am currently executing along with a model portfolio of attractive biotech stocks, just initiate your free trial into The Biotech Forum by clicking HERE .Shares of gene and cell therapy concern Precigen, Inc. (NASDAQ: PGEN ) have rallied substantially since its recurrent respiratory papillomatosis therapy Papzimeos received full approval from the FDA on August 14th. The first-ever approv ...